Previous issues
P. A. Van Zwieten, MD
Head of Departments of Pharmacotherapy, Cardiology, and Cardiopulmonary Surgery,
Academic Medical Center, University of Amsterdam, The Netherlands
Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome
Trang H, Girard A, Lard D, Elghozi JL.
Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension
Head GA, Burke SL.
Comparison of rilmenidine and lisinopril on ambulatory blood pressure and plasma lipid and glucose levels in hypertensive women with metabolic syndrome
Esler M, Lux A, Jennings G, et al.
Short term blood pressure and heart rate variability in congenital central hypoventilation syndrome (Ondine’s curse)
Trang H, Girard A, Lard D, Elghozi JL.
Sympathetic responses to stress and rilmenidine in 2K-1C rabbits
Head GA, Burke SL.
Rilmenidine sympatholytic activity preserves mental stress, orthostatic sympathetic responses and adrenaline secretion
Esler M, Lux A, Jennings G, et al.
Effects of rilmenidine on the baroreflex
Harron DWG.
Prognostic value of home heart rate for cardiovascular mortality in the general population
Hozawa A et al.
How to assess sympathetic activity in humans.
Grassi G, Esler M.
Relationship between central sympathetic activity and
stages of human hypertension
Smith PA, Graham LY, Mackinfosh AF, Stroker JB, Mary DASG.
Rilmenidine sympatholytic activity
preserves mental stress, orthostatic sympathetic responses and adrenaline secretion
Esler M, Lux A, Jenning G, Hastings J, Socratous F, Lambert G.
Causes and consequences of increased
sympathetic activity in renal disease.
J.A. Joles, H.A. Koolmans.
Sympathetic responses to stress and
rilmenidine in 2K1C rabbits. Evidence of enhanced nonvascular effector mechanism.
G.A. Head, S.L. Burke.
Effects of low dose sympathetic inhibition
on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.
K. Amann, L.C. Rump, A. Simonaviciene, et al.
Peripheral and central
interactions between the renin-angiotensin system and the renal sympathetic
nerves in control of renal function.
Di Bona GF.
Sympathetic deactivation as a goal
of non pharmacologic and pharmacologic antihypertensive treatment: rationale
and options.
Grassi G.
The sympathetic nervous system and
the renin-angiotensin-aldosterone system in cardiovascular disease.
Cody RJ.
Sympathetic overactivity
in the etiology of obstructive sleep apnea.
E. C. Fletcher
Raised sympathetic nerve
activity in heart failure and central sleep apnea is due to heart failure
severity.
D. Mansfield, D. M. Kaye, H. P. Brunner La Rocca, et al.
Cardiovascular effects
of continuous positive airway pressure in patients with heart failure and
obstructive sleep apnea.
Y. Kaneko, J. S. Floras, K. Usui, et al.
Evidence of a selective
increase in cardiac sympathetic activity in patients with sustained ventricular
arrhythmias.
Meredith IT, Broughton A, Jennings GL, Esler MD.
Preventive effect of
rilmenidine on the occurrence of neurogenic ventricular arrhythmias in rabbits
Roegel JC, Yannoulis N, De Jong W, Feldman J, Bousquet P.
Protective effects of
centrally acting sympathomodulatory drugs on myocardial ischemia induced by
sympathetic overactivity in rabbits
Catelli M, Feldman J, Bousquet P, Tibiriça E.
Effects of chronic clonidine
administration on sympathetic nerve traffic and baroreflex function in heart
failure.
Grassi G, Turric C, Seravelle G, Bertinieri G, Pierini A, Mancia G.
Norepinehrine turnover
is increased in suprabulbar subcortical brain regions and is related to whole-body
sympathetic activity in human heart failure.
Aggarwal A, Esler MD, Lambert GW, Hastings J, Johnston L, Kaye DM.
Preservation of the
baroreceptor heart rate reflex by chemical sympathectomy in experimental heart
failure.
Mircoli L, Fedele L, Benetti M, et al.
The effect of chronic
rilmenidine on baroreflexes in 2k1c hypertensive rabbits
Burke SL, Head GA
Sympathetic overactivity
as a cause of hypertension in chronic renal failure
Augustyniak RA, Tuncel M, Zhang W, Toto RD, Victor RG.
Functionally specific
renal sympathetic nerve fibers: role in cardiovascular regulation
DiBona GF
Respective contribution
of α-adrenergic and non-adrenergic mechanisms in the hypotensive effect
of imidazoline-like drugs.
Bruban V, Feldman J, Greney H, et al.
Evidence for synergy
between α2-adrenergic and nonadrenergic mechanisms in central
blood pressure regulation.
Bruban V, Estato V, Schann S, Ehrhardt J D, et al.
Does it make sense to
develop new centrally acting cardiovascular drugs?
Bousquet P, Monassier L, Feldman J.
Why is reduced heart rate beneficial?
A. Boraso
Age-associated arterial wall thickening
is related to elevations in sympathetic activity in healthy humans.
F.A. Dinenno, P.P. Jones, D.R. Seals and H. Tanaka.
The sympathetic neurobiology of essential
hypertension: disparate influences of obesity, stress and noradrenaline transporter
dysfunction?
M. Esler, M. Rumantir, D. Kaye, G. Lambert
The autonomic nervous system in arterial
hypertension: what is new?
Elghozi JL, Herpin O.
Differentiated response of the sympathetic
nervous system to angiotensinconverting enzyme inhibition in hypertension.
Johansson M, Elam M, Rundqvist B, et al.
Sympathetic nervous system in acute
and chronic blood pressure elevation.
Izzo JL.
Adrenergic and reflex abnormalities
in obesity-related hypertension.
Grassi G, Seravalle G, Dell’Oro R, Turri C, Bolla GB, Mancia G.
Ethnic differences in insulinemia and
sympathetic tone as links between obesity and blood pressure.
Weyer C, Pratley RE, Snitker S, Spraul M, Ravussin E, Tataranni PA.
Effect of rilmenidine, a centrally acting
imidazoline agonist on the reninangiotensin - aldosterone and catecholamine
system and on the parameters indicating oxidative stress in patients with essential
hypertension.
Nemes J, Röth E, Kapronczay P, Nemes O, Mozsik G
Overweight and hypertension. A 2-way
street ?
Julius S, Valentini M, Palatini P.
Cardiovascular variability after rilmenidine
challenge: assessment of acute dosing effects by means of spectral analysis.
Girard A, Février B, Elghozi JL..
Muscle and skin sympathetic nerve traffic
during the "white coat" effect.
Grassi G, Turri C, Vailati S, Dell’Oro R, Mancia G
Rilmenidine in the hypertensive type
2 diabetic: a controlled pilot study versus captopril
B. Bauduceau, H. Mayaudon, O. Dupuy.
Impaired baroflex sensitivity and sympathovagal
balance in syndrome X.
S. Adamopoulo, G. M. Rosano, P. Poniknowski, et al.
Insulin-resistant prediabetic subjects
have more atherogenic risk factors than insulin-sensitive prediabetic subjects
S. Haffner, L. Mykkänen, A. Fosta, et al.
|
